Conestoga Capital Advisors, LLC Repligen Corp Transaction History

Conestoga Capital Advisors, LLC

$6.87 Billion
Q1 2024

A detailed history of Conestoga Capital Advisors, LLC transactions in Repligen Corp stock. As of the latest transaction made, Conestoga Capital Advisors, LLC holds 747,555 shares of RGEN stock, worth $111 Million. This represents 2.0% of its overall portfolio holdings.

Number of Shares

747,555

Previous 709,738 5.33%

Holding current value

$111 Million

Previous $128 Million 7.74%

% of portfolio

2.0%

Previous 1.93%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 26, 2024	BUY	$170.78 - $208.42 $6.46 Million - $7.88 Million	37,817 Added 5.33%	747,555 $137 Million
Q4 2023 Jan 26, 2024	BUY	$114.17 - $185.35 $295,700 - $480,056	2,590 Added 0.37%	709,738 $128 Million
Q3 2023 Oct 27, 2023	BUY	$138.78 - $176.51 $3.41 Million - $4.34 Million	24,593 Added 3.6%	707,148 $112 Million
Q2 2023 Jul 28, 2023	SELL	$138.42 - $180.31 $399,480 - $520,374	-2,886 Reduced 0.42%	682,555 $96.6 Million
Q1 2023 Apr 21, 2023	BUY	$154.26 - $198.1 $558,883 - $717,716	3,623 Added 0.53%	685,441 $115 Million

Q4 2022 Jan 31, 2023	BUY	$162.42 - $220.56 $122,627 - $166,522	755 Added 0.11%	681,818 $115 Million
Q3 2022 Oct 24, 2022	SELL	$160.42 - $256.21 $13.8 Million - $22.1 Million	-86,236 Reduced 11.24%	681,063 $127 Million
Q2 2022 Jul 22, 2022	SELL	$140.68 - $188.02 $762,485 - $1.02 Million	-5,420 Reduced 0.7%	767,299 $125 Million
Q1 2022 Apr 25, 2022	BUY	$161.19 - $257.96 $19.2 Million - $30.7 Million	118,818 Added 18.17%	772,719 $145 Million
Q4 2021 Jan 21, 2022	SELL	$247.59 - $304.47 $53.8 Million - $66.2 Million	-217,489 Reduced 24.96%	653,901 $173 Million
Q3 2021 Oct 22, 2021	SELL	$194.77 - $324.21 $29.6 Million - $49.2 Million	-151,885 Reduced 14.84%	871,390 $252 Million
Q2 2021 Jul 27, 2021	SELL	$165.87 - $220.95 $679,237 - $904,790	-4,095 Reduced 0.4%	1,023,275 $204 Million
Q1 2021 Apr 23, 2021	BUY	$180.37 - $226.26 $983,377 - $1.23 Million	5,452 Added 0.53%	1,027,370 $200 Million
Q4 2020 Jan 26, 2021	SELL	$148.08 - $206.57 $21.3 Million - $29.7 Million	-143,698 Reduced 12.33%	1,021,918 $196 Million
Q3 2020 Oct 23, 2020	BUY	$122.51 - $158.27 $6.95 Million - $8.98 Million	56,722 Added 5.12%	1,165,616 $172 Million
Q2 2020 Aug 03, 2020	SELL	$94.33 - $140.48 $22.1 Million - $32.9 Million	-233,945 Reduced 17.42%	1,108,894 $137 Million
Q1 2020 Apr 17, 2020	BUY	$84.96 - $109.14 $6.58 Million - $8.46 Million	77,505 Added 6.13%	1,342,839 $130 Million
Q4 2019 Jan 24, 2020	SELL	$73.84 - $93.08 $1.01 Million - $1.27 Million	-13,645 Reduced 1.07%	1,265,334 $117 Million
Q3 2019 Oct 25, 2019	SELL	$76.65 - $95.51 $32.1 Million - $40.1 Million	-419,350 Reduced 24.69%	1,278,979 $98.1 Million
Q2 2019 Aug 02, 2019	BUY	$54.2 - $85.95 $3.3 Million - $5.23 Million	60,899 Added 3.72%	1,698,329 $146 Million
Q1 2019 Apr 18, 2019	BUY	$49.45 - $62.8 $1.06 Million - $1.34 Million	21,393 Added 1.32%	1,637,430 $96.7 Million
Q4 2018 Jan 28, 2019	SELL	$48.26 - $68.88 $15.7 Million - $22.4 Million	-325,175 Reduced 16.75%	1,616,037 $85.2 Million
Q3 2018 Oct 25, 2018	BUY	$46.8 - $58.97 $10.8 Million - $13.6 Million	230,080 Added 13.45%	1,941,212 $108 Million
Q2 2018 Jul 20, 2018	BUY	$35.26 - $47.04 $3.78 Million - $5.04 Million	107,095 Added 6.68%	1,711,132 $80.5 Million
Q1 2018 Apr 24, 2018	SELL	$30.92 - $37.27 $2.03 Million - $2.44 Million	-65,525 Reduced 3.92%	1,604,037 $58 Million
Q4 2017 Jan 22, 2018	BUY	$32.53 - $38.92 $7.04 Million - $8.42 Million	216,330 Added 14.89%	1,669,562 $60.6 Million
Q3 2017 Oct 20, 2017	BUY	$36.98 - $46.06 $53.7 Million - $66.9 Million	1,453,232	1,453,232 $55.7 Million

Others Institutions Holding RGEN

# of Institutions

522

Shares Held

53.2M

Call Options Held

1.05M

Put Options Held

228K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.27B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Conestoga Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Conestoga Capital Advisors, LLC with notifications on news.

Account

Conestoga Capital Advisors, LLC Repligen Corp Transaction History